Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-03

FDA Approved: FAMOTIDINE — Original Application (Ascent Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approves the original generic application for famotidine by Ascent Pharmaceuticals, Inc., enabling a generic version of this H2 blocker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (generic) (famotidine)

Snippet

ORIG AP for FAMOTIDINE (FAMOTIDINE)